Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2015, Article ID 970354, 6 pages
http://dx.doi.org/10.1155/2015/970354
Research Article

Protective Effects of Streblus asper Leaf Extract on H2O2-Induced ROS in SK-N-SH Cells and MPTP-Induced Parkinson’s Disease-Like Symptoms in C57BL/6 Mouse

Department of Pharmacology, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand

Received 15 October 2015; Accepted 7 December 2015

Academic Editor: Giuseppe Esposito

Copyright © 2015 Kanathip Singsai et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. K. Glass, K. Saijo, B. Winner, M. C. Marchetto, and F. H. Gage, “Mechanisms underlying inflammation in neurodegeneration,” Cell, vol. 140, no. 6, pp. 918–934, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. X.-Z. Li, S.-N. Zhang, S.-M. Liu, and F. Lu, “Recent advances in herbal medicines treating Parkinson's disease,” Fitoterapia, vol. 84, no. 1, pp. 273–285, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. W. Poewe, A. Antonini, J. C. Zijlmans, P. R. Burkhard, and F. Vingerhoets, “Levodopa in the treatment of Parkinson's disease: an old drug still going strong,” Clinical Interventions in Aging, vol. 5, pp. 229–238, 2010. View at Google Scholar · View at Scopus
  4. S. Rastogi, D. K. Kulshreshtha, and A. K. S. Rawat, “Streblus asper Lour. (Shakhotaka): a review of its chemical, pharmacological and ethnomedicinal properties,” Evidence-Based Complementary and Alternative Medicine, vol. 3, no. 2, pp. 217–222, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Wongkham, P. Laupattarakasaem, K. Pienthaweechai, P. Areejitranusorn, C. Wongkham, and T. Techanitiswad, “Antimicrobial activity of Streblus asper leaf extract,” Phytotherapy Research, vol. 15, no. 2, pp. 119–121, 2001. View at Publisher · View at Google Scholar
  6. B. Sripanidkulchai, J. Junlatat, N. Wara-aswapati, and D. Hormdee, “Anti-inflammatory effect of Streblus asper leaf extract in rats and its modulation on inflammation-associated genes expression in RAW 264.7 macrophage cells,” Journal of Ethnopharmacology, vol. 124, no. 3, pp. 566–570, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. R. B. Kumar, B. Kar, N. Dolai et al., “Antitumor activity and antioxidant role of Streblus asper bark against Ehrlich ascites carcinoma in Swiss albino mice,” Journal of Experimental Therapeutics and Oncology, vol. 10, no. 3, pp. 197–202, 2013. View at Google Scholar
  8. N. M. Ibrahim, I. Mat, V. Lim, and R. Ahmad, “Antioxidant activity and phenolic content of Streblus asper leaves from various drying methods,” Antioxidants, vol. 2, no. 3, pp. 156–166, 2013. View at Publisher · View at Google Scholar
  9. M. Alothman, R. Bhat, and A. A. Karim, “Antioxidant capacity and phenolic content of selected tropical fruits from Malaysia, extracted with different solvents,” Food Chemistry, vol. 115, no. 3, pp. 785–788, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Sattayasai, P. Chaonapan, T. Arkaravichie et al., “Protective effects of mangosteen extract on H2O2-induced cytotoxicity in SK-N-SH cells and scopolamine-induced memory impairment in mice,” PLoS ONE, vol. 8, no. 12, Article ID e85053, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. T. Araki, T. Kumagai, K. Tanaka et al., “Neuroprotective effect of riluzole in MPTP-treated mice,” Brain Research, vol. 918, no. 1-2, pp. 176–181, 2001. View at Publisher · View at Google Scholar · View at Scopus
  12. C. Gibrat, M. Saint-Pierre, M. Bousquet, D. Lévesque, C. Rouillard, and F. Cicchetti, “Differences between subacute and chronic MPTP mice models: investigation of dopaminergic neuronal degeneration and α-synuclein inclusions,” Journal of Neurochemistry, vol. 109, no. 5, pp. 1469–1482, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Sathiya, V. Ranju, P. Kalaivani et al., “Telmisartan attenuates MPTP induced dopaminergic degeneration and motor dysfunction through regulation of alpha-synuclein and neurotrophic factors (BDNF and GDNF) expression in C57BL/6J mice,” Neuropharmacology, vol. 73, pp. 98–110, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. E. Esposito, D. Impellizzeri, E. Mazzon, I. Paterniti, and S. Cuzzocrea, “Neuroprotective activities of palmitoylethanolamide in an animal model of Parkinson's disease,” PLoS ONE, vol. 7, no. 8, Article ID e41880, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. P. Curzon, M. Zhang, R. J. Radek, and G. B. Fox, “The behavioral assessment of sensorimotor processes in the mouse: acoustic startle, sensory gating, locomotor activity, rotarod, and beam walking,” in Methods of Behavior Analysis in Neuroscience, J. J. Buccafusco, Ed., pp. 1–20, CRC Press, Boca Raton, Fla, USA, 2009. View at Google Scholar
  16. R. D. S. Prediger, A. S. Aguiar Jr., A. E. Rojas-Mayorquin et al., “Single intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in C57BL/6 mice models early preclinical phase of Parkinson's disease,” Neurotoxicity Research, vol. 17, no. 2, pp. 114–129, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. K. J. Barnham, C. L. Masters, and A. I. Bush, “Neurodegenerative diseases and oxidative stress,” Nature Reviews Drug Discovery, vol. 3, no. 3, pp. 205–214, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. G. Cappellano, M. Carecchio, T. Fleetwood et al., “Immunity and inflammation in neurodegenerative diseases,” American Journal of Neurodegenerative Disease, vol. 2, no. 2, pp. 89–107, 2013. View at Google Scholar
  19. W. Dauer and S. Przedborski, “Parkinson's disease: mechanisms and models,” Neuron, vol. 39, no. 6, pp. 889–909, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Hald and J. Lotharius, “Oxidative stress and inflammation in Parkinson's disease: is there a causal link?” Experimental Neurology, vol. 193, no. 2, pp. 279–290, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. R. L. Mosley, E. J. Benner, I. Kadiu et al., “Neuroinflammation, oxidative stress, and the pathogenesis of Parkinson's disease,” Clinical Neuroscience Research, vol. 6, no. 5, pp. 261–281, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Przedborski, V. Jackson-Lewis, M. Vila et al., “Free radical and nitric oxide toxicity in Parkinson's disease,” Advances in Neurology, vol. 91, pp. 83–94, 2003. View at Google Scholar · View at Scopus
  23. E. Trushina and C. T. McMurray, “Oxidative stress and mitochondrial dysfunction in neurodegenerative diseases,” Neuroscience, vol. 145, no. 4, pp. 1233–1248, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. J. Blesa, S. Phani, V. Jackson-Lewis, and S. Przedborski, “Classic and new animal models of Parkinson's disease,” Journal of Biomedicine and Biotechnology, vol. 2012, Article ID 845618, 10 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. S. M. Afjalus, M. Salahuddin, M. Rahman, A. Khatun, and F. Yasmin, “Investigation of analgesic and antioxidant of ethanolic extract of Streblus asper Lour. (Moraceae) leaf and bark,” International Research Journal of Pharmacy, vol. 4, no. 1, pp. 262–266, 2013. View at Google Scholar
  26. C. Li, C. Huang, T. Lu et al., “Tandem mass spectrometric fragmentation behavior of lignans, flavonoids and triterpenoids in Streblus asper,” Rapid Communications in Mass Spectrometry, vol. 28, no. 21, pp. 2363–2370, 2014. View at Publisher · View at Google Scholar
  27. G. Filomeni, I. Graziani, D. De Zio et al., “Neuroprotection of kaempferol by autophagy in models of rotenone-mediated acute toxicity: possible implications for Parkinson's disease,” Neurobiology of Aging, vol. 33, no. 4, pp. 767–785, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Li and X.-P. Pu, “Neuroprotective effect of kaempferol against a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of Parkinson's disease,” Biological and Pharmaceutical Bulletin, vol. 34, no. 8, pp. 1291–1296, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. Y. Q. Wang, M. Y. Wang, X. R. Fu et al., “Neuroprotective effects of ginkgetin against neuroinjury in Parkinson's disease model induced by MPTP via chelating iron,” Free Radical Research, vol. 49, no. 9, pp. 1069–1080, 2015. View at Publisher · View at Google Scholar
  30. K. Zhang, Z. Ma, J. Wang, A. Xie, and J. Xie, “Myricetin attenuated MPP+-induced cytotoxicity by anti-oxidation and inhibition of MKK4 and JNK activation in MES23.5 cells,” Neuropharmacology, vol. 61, no. 1-2, pp. 329–335, 2011. View at Publisher · View at Google Scholar · View at Scopus